Compare AGD & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGD | SENS |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.6M | 308.5M |
| IPO Year | 2006 | 2014 |
| Metric | AGD | SENS |
|---|---|---|
| Price | $11.98 | $6.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $22.70 |
| AVG Volume (30 Days) | 114.6K | ★ 493.9K |
| Earning Date | 01-01-0001 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $70.20 |
| Revenue Next Year | N/A | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $8.46 | $0.41 |
| 52 Week High | $13.98 | $8.75 |
| Indicator | AGD | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 43.42 |
| Support Level | $11.17 | $5.46 |
| Resistance Level | $12.35 | $8.55 |
| Average True Range (ATR) | 0.23 | 0.54 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 48.57 | 33.55 |
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors, among others.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.